Performance Highlights - H1 FY27
Financial Performance (Consolidated, ₹ crores):
- Revenue from Operations: ₹48.9 crore, up 8% YoY from ₹45.2 crore in H1 FY26
- Operating Expense + Cost of Material Consumed: ₹20.5 crore, up 23% YoY
- Employee Benefits Expense: ₹5.1 crore, up 23% YoY
- Other Expenses: ₹9.3 crore, up 30% YoY
- EBITDA: ₹14.1 crore, down 18% YoY
- EBITDA Margin: 28.9%, declined 936 bps from 38.2% in H1 FY26
- Finance Costs: ₹0.33 crore, reduced 74% YoY
- Profit Before Tax: ₹10.7 crore, down 21% YoY
- Profit After Tax: ₹7.8 crore, down 22% YoY
- PAT Margin: 16.0%, declined 623 bps from 22.2% in H1 FY26
Service-wise Revenue Breakdown (H1 FY27):
- Radiology: ₹39.7 crore (6% YoY growth)
- Pathology: ₹7.6 crore (17% YoY growth)
- Cardiology: ₹1.3 crore (22% YoY growth)
- Neurology: ₹0.2 crore (20% YoY growth)
- Urology: ₹0.1 crore (47% YoY growth)
- Total: ₹48.9 crore
Balance Sheet Position (H1 FY27, ₹ crores):
- Total Assets: ₹150.9 crore
- Property, Plant and Equipment: ₹28.6 crore
- Trade Receivables: ₹64.0 crore
- Cash & Cash Equivalents: ₹26.0 crore
- Total Shareholders' Equity: ₹123.9 crore
- Long-term Borrowings: ₹2.5 crore
- Short-term Borrowings: ₹11.9 crore
Cash Flow Statement (H1 FY27, ₹ crores):
- Net Cash from Operating Activities: (₹6.2) crore
- Net Cash from Investing Activities: (₹12.8) crore
- Net Cash from Financing Activities: (₹6.6) crore
- Net Decrease in Cash: (₹25.6) crore
Operational and Business Updates
Business Model Reclassification:
- One business previously classified under B2C has been correctly reclassified under B2B
- Current business model segments: B2G (government and PPP), B2B (hospital tie-ups), B2C (direct-to-patient)
Network Expansion:
- B2B hospital tie-up network expanded by 40-45 additional hospitals
- Total B2B network now stands at 150+ tie-ups
- Geographic presence: Delhi, Uttar Pradesh, Maharashtra (Nasik)
Technology Enhancements:
- Installed high-end 640-slice CT scanner to enhance advanced imaging capabilities
- Implementing ERP system to streamline operations, accounting, and inter-department integration
- IT tools include LIS, PACS, Augnito (Voice AI), Tally, SanCCS (Call Center), Freedom Modality
- Specialized tools: Motic (Cytology Imaging), Priscca (Double/Triple Marker Testing)
PPP Operations:
- B2G revenue: ₹1.7 crores through royalty-based model
- Collaborating with governments of Uttar Pradesh, Delhi, and Nashik under PPP model
- Set up Radiology Unit with 1.5T MRI and 16-slice CT scan machine in Delhi
- Three PPP projects currently in pipeline for execution
Growth Strategy and Future Plans
Near-term Initiatives:
- Commissioning of full-fledged Dwarka diagnostic centre by end-November 2026 (subject to PCPNDT approval)
- Expected annual revenue from Dwarka centre: ₹5-6 crore in initial years
- Equipment: CT scan, MRI, ultrasound, X-ray facilities
Expansion Plans:
- Expand RG Stone collaboration with additional CT scan facility in Faridabad
- Expand diagnostic network into Gurgaon and Noida
- Increase MRI capacity at Tilak Nagar
- Establish dedicated laboratory infrastructure for genome sequencing
Capital Expenditure:
- Planned FY27 capex: ₹20-25 crore towards diagnostic equipment and centre construction
- Supporting company's 20-25% annual revenue growth ambition
Debt Position:
- Progressing towards debt-free position
- Two loans fully repaid during the period
- Significant decline in interest expenses
Management Commentary
- Growth driven by stronger B2B partnerships, rising B2C activity, and improved operational efficiencies across existing centres
- Enhanced operational efficiency and capacity utilisation across existing diagnostic centres
- Strengthening B2C contribution to reduce dependence on government receivables and support positive operating cash flows
- Making diagnostic services available to broader population through government collaborations
Leadership Team
- Mr. Pawan Gupta: Chairman and Managing Director (B.Com from Dr. Bhimrao Ambedkar University, 2000)
- Dr. Sameer Sood: Non-Executive Director (Radiologist with 28 years association, MD Radio-Diagnosis from AIIMS)
- Ms. Neelam Ratra: Executive Director (MBA in Hospital Administration, previously with Ayushman Hospital)
- Ms. Chhaya Gupta: Executive Director (MBA in International Business Management, 7.5 years experience)